Institute Report
Pathway to Success in Cancer Treatment
Achieving Radioligand Therapy Capacity and Readiness in Europe – A Public Working Session
Aug 23, 2024
Download

The introduction of innovative treatments in the healthcare system can lead to challenges for timely and effective diagnosis and treatment. In December 2023, the IQVIA Institute published a report on The State of Radioligand Therapy Readiness in Europe. This report established key data quantifying the readiness and highlighted the challenges that could restrict this treatment from reaching eligible patients on time, as well as key levers that need to be improved upon. Building on this report, a public working session was organized at the European Parliament on April 11, 2024, hosted by European Parliament Member Niels Geuking.

The objective of this session was to discuss recommendations and actions that can help overcome the previously identified challenges. This discussion took place with a multi-stakeholder panel representing key interest groups. A set of recommendations and actions were reviewed by the panelists prior to and during the public working session, and panelists discussed perspectives and actions building on the initial set of recommendations.

This proceedings document provides a short background of the key issues and challenges with the implementation of radioligand therapies. Subsequently, it summarizes the discussions and recommendations from prior meetings with panelists and from the session. The learnings from the sessions apply not only to radioligand therapies but also highlight the types of policies and actions that need to be considered as innovative therapies continue to enter the cancer care paradigm

Contact Us